AG-013,958
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG-013,958, covering 2011-05-27 to 2011-05-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]